HealthcareServices

Gouty Arthritis Market Forecast: How Big Will It Be by 2030?

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the gouty arthritis market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Gouty Arthritis Market?

The gouty arthritis market has shown robust expansion in recent years. Its valuation is expected to rise from $3.69 billion in 2025 to $3.96 billion in 2026, driven by a compound annual growth rate (CAGR) of 7.2%. Factors contributing to its historical growth include evolving dietary patterns, the widespread availability of NSAIDs, a higher rate of arthritis diagnoses, the establishment of more rheumatology clinics, and advancements in pain management drug development.

The gouty arthritis market is projected to experience substantial expansion in the coming years, forecast to reach $5.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This anticipated growth is driven by factors such as an expanding aging population, heightened awareness of chronic diseases, proactive arthritis care measures, enhanced patient adherence, and tailored approaches to gout treatment. Key developments expected during this period involve the increasing occurrence of hyperuricemia, a growing need for sustained disease management, the rise of combination drug regimens, broader integration of advanced diagnostic imaging, and the expansion of lifestyle-focused disease management strategies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp

Which Drivers Are Supporting The Rise Of The Gouty Arthritis Market?

The rising incidence of obesity is projected to boost expansion within the gouty arthritis market in the coming years. Obesity, a medical condition, involves an excessive accumulation of body fat that poses risks to an individual’s well-being, often assessed via the body mass index (BMI). The growing rates of obesity are attributable to greater intake of high-calorie, processed foods and less active lifestyles. This condition contributes to gouty arthritis by heightening uric acid production and diminishing the body’s capacity to expel it, resulting in the build-up of uric acid crystals in the joints. Furthermore, surplus body weight exerts additional strain on joints, intensifying the inflammation and discomfort associated with gout. For example, in May 2025, data from the Office for Health Improvement and Disparities, a UK government organization, indicated that an estimated 64.5% of adults aged 18 and above in England were classified as overweight or living with obesity between 2023 and 2024, an increase from 64.0% recorded from 2022 to 2023. Consequently, the increasing prevalence of obesity is propelling the growth of the gouty arthritis market.

What Leading Segments Are Studied In The Gouty Arthritis Market?

The gouty arthritis market covered in this report is segmented –

1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis

2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Other Treatments

3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities

2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)

What Long-Term Trends Are Expected To Shape The Future Of The Gouty Arthritis Market?

Major companies engaged in the gouty arthritis market are increasing their endeavors to develop innovative products, such as cortrophin gel, aiming to provide more effective and targeted therapies for managing the condition. Cortrophin gel, also recognized as repository corticotropin injection, is a refined form of the adrenocorticotropic hormone (ACTH). It is utilized in the treatment of various inflammatory and autoimmune conditions, including gouty arthritis. For instance, in October 2023, ANI Pharmaceuticals, a US-based pharmaceutical firm, obtained approval from the Food and Drug Administration for a new 1-mL vial size of Purified Cortrophin Gel. This product is designed for the adjunctive treatment of specific patients experiencing acute gouty arthritis flares. Cortrophin Gel remains the sole FDA-approved adrenocorticotropic hormone (ACTH) therapy currently indicated for treating appropriate patients with acute gouty arthritis flares.

Which Major Firms Are Strengthening Their Position In The Gouty Arthritis Market?

Major companies operating in the gouty arthritis market are Horizon Therapeutics plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Novartis International AG, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Teijin Pharma Ltd, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, JW Pharmaceutical, Arthrosi Therapeutics Ltd, XORTX Therapeutics Inc, Atom Therapeutics Co Ltd, Olatec Therapeutics LLC, InventisBio Co Ltd, Shanton Pharma, Selecta Biosciences Inc, LG Chem Ltd, Protalix BioTherapeutics Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Gouty Arthritis Market?

North America was the largest region in the gouty arthritis market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gouty Arthritis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16070&type=smp

Browse Through More Reports Similar to the Global Gouty Arthritis Market 2026, By The Business Research Company

Emollients Market Report 2026

https://www.thebusinessresearchcompany.com/report/emollients-global-market-report

Gout Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Osteoarthritis Market Report 2026

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795